|
|
| | UNBS-5162 Basic information |
| Product Name: | UNBS-5162 | | Synonyms: | UNBS-5162;CS-1759;UNBS 5162; UNBS-5162;1-(2-(2-(Dimethylamino)ethyl)-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-5-yl)urea;1-(2-(2-(dimethylamino)ethyl)-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-5-yl)urea UNBS-5162;UNBS-5162, >=98%;[2-[2-(dimethylamino)ethyl]-1,3-dioxobenzo[de]isoquinolin-5-yl]urea;Uunbs-5162 | | CAS: | 956590-23-1 | | MF: | C17H18N4O3 | | MW: | 326.35 | | EINECS: | | | Product Categories: | Inhibitors | | Mol File: | 956590-23-1.mol |  |
| | UNBS-5162 Chemical Properties |
| Boiling point | 526.4±35.0 °C(Predicted) | | density | 1.389±0.06 g/cm3(Predicted) | | storage temp. | under inert gas (nitrogen or Argon) at 2-8°C | | solubility | Soluble in DMSO | | form | crystalline solid | | pka | 13.50±0.20(Predicted) | | color | Light yellow to yellow | | InChI | 1S/C17H18N4O3/c1-20(2)6-7-21-15(22)12-5-3-4-10-8-11(19-17(18)24)9-13(14(10)12)16(21)23/h3-5,8-9H,6-7H2,1-2H3,(H3,18,19,24) | | InChIKey | WCKZRLOUKYFJDY-UHFFFAOYSA-N | | SMILES | [n]1([c](c2c3c([c]1=O)cccc3cc(c2)NC(=O)N)=O)CCN(C)C |
| WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids |
| | UNBS-5162 Usage And Synthesis |
| Uses | UNBS5162 is a pan-antagonist of CXCL chemokine expression, with anti-tumor activity. | | Biological Activity | UNBS5162, an amonafide (naphthalimide) derivative, is a potent antitumor agent th at inhibits tumor proliferation, progression and invasiveness. UNBS5162 is a pan-antagonist of CXCL chemokine expression. It appears th at UNBS5162 inhibits melanoma progression through inhibition of the AKT/mTOR signaling pathway. | | in vivo | UNBS5162 (20 mg/kg, i.v.) increases the therapeutic benefits of taxol in vivo in the orthotopic human PC-3 prostate cancer model[1]. | | IC 50 | CXCL | | References | [1] Mijatovic T, et al. UNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers. Neoplasia. 2008 Jun;10(6):573-86. DOI:10.1593/neo.08290 [2] Tina Mahieu, et al. UNBS5162: A novel naphthalimide derivative with potent pro-autophagic effects in human cancer cells. Cancer Research, 2007 May; 67(9) Supplement. [3] He D, et al. UNBS5162 inhibits the proliferation of esophageal cancer squamous cells via the PI3K/AKT signaling pathway. Mol Med Rep. 2018 Jan;17(1):549-555. DOI:10.3892/mmr.2017.7893 |
| | UNBS-5162 Preparation Products And Raw materials |
|